Skip to search.
 TSX Up 0.16% TSX Ventures  0.00%
Streaming
Ticker Tape: On

More On HBP.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Helix BioPharma Corp (HBP.TO)

-Toronto
1.60 Down 0.06(3.61%) 10:50AM EDT
Add to Portfolio
Prev Close:1.66
Open:1.60
Bid:1.51
Ask:1.79
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:1.60 - 1.60
52wk Range:0.73 - 1.77
Volume:1,100
Avg Vol (3m):12,908
Market Cap:115.05M
P/E (ttm):N/A
EPS (ttm):N/A
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Headlines

Must Read

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Helix BioPharma Corp., a biopharmaceutical company, develops drugs for the prevention and treatment of cancer based on its proprietary technologies. The company focuses on the development of L-DOS47 that is in phase I/II clinical trial for the tre... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback